Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03373760 |
|---|---|
| Brief Title: | Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer |
| First Submitted : | December 11, 2017 |
| First Submitted that Met QC Criteria : | December 11, 2017 |
| First Posted : | December 14, 2017 |
| Results First Submitted : | November 8, 2021 |
| Results First Posted with QC Comments : | December 9, 2021 |
| Results First Submitted that Met QC Criteria : | December 22, 2021 |
| Results First Posted : | January 21, 2022 |
| Last Update Submitted that Met QC Criteria : | June 7, 2023 |
| Last Update Posted : | June 9, 2023 |